Works matching IS 11738804 AND DT 2023 AND VI 37 AND IP 4

Results: 11

Base Editing and Prime Editing: Potential Therapeutic Options for Rare and Common Diseases.

Published in:

BioDrugs, 2023, v. 37, n. 4, p. 453, doi. 10.1007/s40259-023-00610-9

By:

Testa, Lauren C.;
Musunuru, Kiran

Publication type:

Article

Antibody–Drug Conjugates in the Treatment of Urothelial Cancer.

Published in:

BioDrugs, 2023, v. 37, n. 4, p. 505, doi. 10.1007/s40259-023-00606-5

By:

Singh, Avani M.;
Guevara-Patino, Jose A.;
Wang, Xuefeng;
Li, Roger;
Sonpavde, Guru;
Jain, Rohit K.

Publication type:

Article

Historical Overview of Regulatory Approvals and PMDA Assessments for Biosimilar Products in Japan During 2009–2022.

Published in:

BioDrugs, 2023, v. 37, n. 4, p. 443, doi. 10.1007/s40259-023-00605-6

By:

Kuribayashi, Ryosuke;
Nakano, Ayuki;
Hariu, Aya;
Kishioka, Yasuhiro;
Honda, Futaba

Publication type:

Article

The Role of Biologics in the Treatment of Chronic Rhinosinusitis.

Published in:

BioDrugs, 2023, v. 37, n. 4, p. 477, doi. 10.1007/s40259-023-00602-9

By:

Haloob, Nora;
Karamali, Katerina;
Hopkins, Claire

Publication type:

Article

Assessing the Interchangeability of AVT02 and Humira<sup>®</sup> in Participants with Moderate‑to‑Severe Chronic Plaque Psoriasis: Pharmacokinetics, Efficacy, Safety, and Immunogenicity Results from a Multicenter, Double-Blind, Randomized, Parallel-Group Study

Published in:

BioDrugs, 2023, v. 37, n. 4, p. 551, doi. 10.1007/s40259-023-00600-x

By:

Feldman, Steven R.;
Kay, Richard;
Reznichenko, Nataliya;
Sobierska, Joanna;
Dias, Roshan;
Otto, Hendrik;
Haliduola, Halimu N.;
Sattar, Abid;
Ruffieux, Ruth;
Stroissnig, Heimo;
Berti, Fausto

Publication type:

Article

CAR-T Cells and the Kidney: Insights from the WHO Safety Database.

Published in:

BioDrugs, 2023, v. 37, n. 4, p. 521, doi. 10.1007/s40259-023-00599-1

By:

Gérard, Alexandre O.;
Merino, Diane;
Charbinat, Alexis;
Fournier, Joseph;
Destere, Alexandre;
Loschi, Michael;
Cluzeau, Thomas;
Sicard, Antoine;
Drici, Milou-Daniel

Publication type:

Article

Novel Immunotherapeutic Approaches for the Treatment of Glioblastoma.

Published in:

BioDrugs, 2023, v. 37, n. 4, p. 489, doi. 10.1007/s40259-023-00598-2

By:

Zaidi, Saïf Eddine;
Moelker, Eliese;
Singh, Kirit;
Mohan, Aditya;
Salgado, Miguel A.;
Essibayi, Muhammed Amir;
Hotchkiss, Kelly;
Shen, Steven;
Lee, William;
Sampson, John;
Khasraw, Mustafa

Publication type:

Article

Lupus Nephritis: New and Emerging Biologic and Targeted Therapies.

Published in:

BioDrugs, 2023, v. 37, n. 4, p. 463, doi. 10.1007/s40259-023-00597-3

By:

Kale, Ajinath;
Lech, Maciej;
Anders, Hans-Joachim;
Gaikwad, Anil Bhanudas

Publication type:

Article

Factors Associated with Biosimilar Exclusions and Step Therapy Restrictions Among US Commercial Health Plans.

Published in:

BioDrugs, 2023, v. 37, n. 4, p. 531, doi. 10.1007/s40259-023-00593-7

By:

Yu, Tianzhou;
Jin, Shihan;
Li, Chang;
Chambers, James D.;
Hlávka, Jakub P.

Publication type:

Article

Recurring Fatigue After Biologic Administration: Patient-Reported Data from the Dutch Biologic Monitor.

Published in:

BioDrugs, 2023, v. 37, n. 4, p. 541, doi. 10.1007/s40259-023-00592-8

By:

van Lint, Jette A.;
Jessurun, Naomi T.;
Tas, Sander W.;
Vonkeman, Harald E.;
van Doorn, Martijn B. A.;
Hoentjen, Frank;
Nurmohamed, Michael T.;
van Puijenbroek, Eugene P.;
van den Bemt, Bart J. F.

Publication type:

Article

Characterization for the Similarity Assessment between Proposed Biosimilar SB12 and Eculizumab Reference Product Using a State-of-the-Art Analytical Method.

Published in:

BioDrugs, 2023, v. 37, n. 4, p. 569, doi. 10.1007/s40259-023-00591-9

By:

Kim, Hyunsoo;
Hong, Eunkyoung;
Lee, Jungmin;
Hong, Seokku;
Kim, Jihye;
Cho, Miju;
Kim, Yikwon;
Yoo, Taekyung

Publication type:

Article